A new durg for MD was denied, just like Probuphine. It was just discussed on Bloomberg this morning. I didn't catch the name of the drug or the company. Anyone know about this?
Depends on the details.If it suggests approval is iminent with no serious hoops to jump through then probably over $3.
I would certainly dump CVRR; I expected a serious reduction in divvy but not as bad as .30! So glad I didn't get in it. It will have to get below $15. before I can think about it. Earnings may get worse before they get better.
Anyone have a guess? Haven't seen an announcement yet, but it ought to be soon.A bigger question is how well they do and can they sustain the big divvy.
Go to company website.
Incredible opportunity! A growth stock yielding over 12%. I got 2K at 18.36 and will buy more if it goes under 18.